COMMUNIQUÉS West-GlobeNewswire
-
EUROBIO SCIENTIFIC : Rapport Financier Annuel 2025
29/04/2026 -
Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
29/04/2026 -
Beacon Therapeutics Announces Presentations at the ARVO 2026 Annual Meeting
29/04/2026 -
FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S.
29/04/2026 -
EHS Opens Walsh Ambulatory Pavilion, Expanding Access to Advanced Outpatient Care
29/04/2026 -
Carbios files its 2025 Universal Registration Document
29/04/2026 -
Availabilty of 2026 AGM preparatory documents
29/04/2026 -
Communiqué de presse : Assemblée Générale Annuelle du 29 avril 2026 - Belén Garijo nommée administratrice et Directrice générale de Sanofi
29/04/2026 -
Cristcot to Present Oral Abstract at 2026 Digestive Disease Week (DDW)
29/04/2026 -
EUROBIO SCIENTIFIC : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
29/04/2026 -
CARBIOS annonce la mise à disposition de son Document d’enregistrement universel 2025
29/04/2026 -
Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
29/04/2026 -
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
29/04/2026 -
Cannabis Growers Are Shifting Priorities: Seed Banks to Watch in 2026, According to SeedFinder.eu
29/04/2026 -
Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
29/04/2026 -
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
29/04/2026 -
MindBio Files Patent Applications in 15 World Firsts
29/04/2026 -
Anika Reports First Quarter 2026 Financial Results
29/04/2026 -
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
29/04/2026
Pages